Several methods are introduced to increase the half-life of GLP-1 including: (i) modifying peptides to make them resistant to cleavage by DPP-4, such as exenatide twice daily and lixisenatide, (ii) attaching free fatty acid side chains to liraglutide and semaglutide, which enhances their binding to plasma albumin thereby preventing renal filtration of GLP-1 and prolonging their action in vivo [36, 37], (iii) conjugation of albumin or the Fc fragment of IgG to GLP-1 molecule is used in albiglutide and dulaglutide [37, 38], (iv) development of modified nanoparticles for the controlled release of exenatide-LAR (long-acting release) that provide prolonged release of the peptide [39], and finally, (v) chemical permeation enhancers such as sodium salcaprozate (SNAC) could be utilized to overcome the low permeability and high enzymatic degradation of the gastrointestinal tract of GLP-1 analog that is administrated orally such as semaglutide [40]
Originally developed for diabetes, GLP-1 drugs including Wegovy, Ozempic and Zepbound soared in popularity for their use as a weight loss medication
Scalp health optimization Scalp inflammation, seborrheic dermatitis, and folliculitis can all worsen hair loss during GLP-1 therapy
What is the difference between sermorelin and actual HGH injections? Sermorelin is a growth hormone secretagogue that stimulates the pituitary gland to release endogenous HGH in pulsatile patterns that mimic natural physiology, while exogenous HGH injections provide synthetic human growth hormone directly, bypassing the pituitary and suppressing natural production through negative feedback inhibition
doi: 10.1016/j.clinthera.2011.08.005
The mechanistic processing underlying chronic pain is a complex issue that still needs to be resolved, nevertheless when experienced with AD
